Table II.
Tankyrase inhibitors as therapeutic targets for cancer.
| Author, year | Tankyrase inhibitors | Cancer type | (Refs.) |
|---|---|---|---|
| Stratford et al, 2014 | JW 74 | Osteosarcoma | (79) |
| Tian et al, 2013 | NB | (17) | |
| Huang et al, 2009 | XAV939 | CRC | (15) |
| Busch et al, 2013 | Lung cancer | (52) | |
| Bao et al, 2012 | Breast cancer | (77) | |
| Quackenbush et al, 2016 | AZ1366 | CRC | (78) |
| Busch et al, 2013 | IWR-1 | Lung cancer | (52) |
| Lau et al, 2013 | G007-LK | CRC | (47) |
| Waaler et al, 2012 | JW55 | CRC | (48) |
| Arqués et al, 2016 | NVP-TNKS656 | NSCLC | (76) |
| Wang et al, 2016 | (59) |
NB, neuroblastoma; CRC, colorectal cancer; NSCLC, non-small cell lung cancer.